Publications by authors named "Rangaswamy Chintapatla"
Article Synopsis
- Recent treatment options for advanced classical Hodgkin lymphoma have evolved from the longstanding ABVD regimen, with new combinations showing improved survival rates but also increased side effects.
- A study tested a new treatment protocol (AN+AD) which replaces vinblastine with nivolumab, enrolling patients with treatment-naive stage II bulky or III/IV cHL, leading to promising response rates.
- At the time of analysis, patients showed an 88% complete response rate and a favorable safety profile, suggesting further investigation into this new combination therapy is necessary.
The relationship between renal cell cancer (RCC) and hematologic malignancy (HM) in the same individual has been reported for more than 20 years, and is noted in SEER database studies. Family histories suggest a familial association as well. This study evaluates the occurrence of renal cell cancer and hematologic malignancies in individual patients and families, and the occurrence of age-of-onset anticipation among generations.
View Article and Find Full Text PDFCancer-associated retinopathy (CAR) is a rare autoimmune condition associated with various cancers, causing significant visual impairment. Visual symptoms in CAR may or may not correlate with the extent of systemic disease or its response to chemotherapy, and must be addressed separately from the management of systemic malignancy. Steroids have been the mainstay of CAR therapy.
View Article and Find Full Text PDF